Clinical Trial

Efficacy of Continuous Erector Spinae Plane Block to Reduce Postoperative Pain in Patients Undergoing Unilateral Thoracotomy

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated December 31, 2024 (before its estimated March 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to learn if continuous Erector Spinae Plane Block (ESPB) reduces postoperative pain in patients undergoing unilateral thoracotomy. It will also evaluate the safety and effectiveness of continuous ESPB. The total participants needed will be 30 persons. The main questions it aims to answer are: * Does continuous ESPB lower the intensity of postoperative pain compared to multimodal intravenous analgesia? * Does continuous ESPB increase the time to first analgesic request? * Does continuous ESPB reduce the amount of intravenous opioids required in the first 48 hours after surgery? * Does continuous ESPB improve the overall recovery quality within 48 hours post-surgery? Participants will: * Receive continuous ESPB or multimodal intravenous analgesia after the surgery. * Undergo routine pain assessments, and recovery evaluations using tools like the Visual Analogue Scale (VAS) and Quality of Recovery-15 (QoR-15). * Participate in follow-up visits for data collection on pain, opioid usage, and recovery quality.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-19.
Trial Details
NCT Number NCT06750627
Lead Sponsor Udayana University
Conditions Continuous Erector Spinae Plane Block, Unilateral Thoracotomy
Enrollment 30 participants
Start Date 2025-01-01
Primary Completion 2025-03-31 (estimated)
Study Completion 2025-05-31 (estimated)
Updated on ClinicalTrials.gov 2024-12-31